{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:21Z","timestamp":1790959161759,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Metcalfe"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00432-021-03592-9","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T02:02:42Z","timestamp":1615773762000},"page":"1443-1450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diet-related interventions for cancer-associated cachexia"],"prefix":"10.1007","volume":"147","author":[{"given":"Alan J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-876X","authenticated-orcid":false,"given":"Goldy C.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"issue":"2","key":"3592_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13539-010-0011-5","volume":"1","author":"T Akamizu","year":"2010","unstructured":"Akamizu T, Kangawa K (2010) Ghrelin for cachexia. J Cachexia Sarcop Muscle 1(2):169\u2013176. https:\/\/doi.org\/10.1007\/s13539-010-0011-5","journal-title":"J Cachexia Sarcop Muscle"},{"issue":"2 Suppl 1","key":"3592_CR2","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1053\/j.gastro.2005.11.049","volume":"130","author":"DH Alpers","year":"2006","unstructured":"Alpers DH (2006) Glutamine: do the data support the cause for glutamine supplementation in humans? Gastroenterology 130(2 Suppl 1):S106-116. https:\/\/doi.org\/10.1053\/j.gastro.2005.11.049","journal-title":"Gastroenterology"},{"key":"3592_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2014.11.029","volume":"125","author":"CRR Alves","year":"2015","unstructured":"Alves CRR, Da Cunha TF, Da Paix\u00e3o NA, Brum PC (2015) Aerobic exercise training as therapy for cardiac and cancer cachexia. Life Sci 125:9\u201314. https:\/\/doi.org\/10.1016\/j.lfs.2014.11.029","journal-title":"Life Sci"},{"issue":"1","key":"3592_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11\u201348. https:\/\/doi.org\/10.1016\/j.clnu.2016.07.015","journal-title":"Clin Nutr"},{"issue":"5","key":"3592_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0148607109341804","volume":"33","author":"DA August","year":"2009","unstructured":"August DA, Huhmann MB (2009) A. S. P. E. N. Clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parent Enteral Nutr 33(5):472\u2013500. https:\/\/doi.org\/10.1177\/0148607109341804","journal-title":"J Parent Enteral Nutr"},{"key":"3592_CR6","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH (2018) Cancer-associated cachexia. Nat Rev Disease Primers 4:17105. https:\/\/doi.org\/10.1038\/nrdp.2017.105","journal-title":"Nat Rev Disease Primers"},{"issue":"8","key":"3592_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","volume":"14","author":"J Bauer","year":"2013","unstructured":"Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Boirie Y (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 14(8):542\u2013559. https:\/\/doi.org\/10.1016\/j.jamda.2013.05.021","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"3592_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.clnu.2009.04.011","volume":"28","author":"F Bozzetti","year":"2009","unstructured":"Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M (2009) ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28(4):445\u2013454. https:\/\/doi.org\/10.1016\/j.clnu.2009.04.011","journal-title":"Clin Nutr"},{"issue":"1","key":"3592_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/jenvironpatholtoxicoloncol.2017019057","volume":"36","author":"M Clementino","year":"2017","unstructured":"Clementino M, Shi X, Zhang Z (2017) Prevention of polyphenols against carcinogenesis induced by environmental carcinogens. J Environ Pathol 36(1):87\u201398. https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.2017019057","journal-title":"J Environ Pathol"},{"issue":"5","key":"3592_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1017\/S000711450765795X","volume":"97","author":"R Colomer","year":"2007","unstructured":"Colomer R, Moreno-Nogueira JM, Garc\u00eda-Luna PP, Garc\u00eda-Peris P, Garc\u00eda-de-Lorenzo A, Zarazaga A, Casimiro C (2007) n-3 fatty acids, cancer and cachexia: A systematic review of the literature. Br J Nutr 97(5):823\u2013831. https:\/\/doi.org\/10.1017\/S000711450765795X","journal-title":"Br J Nutr"},{"issue":"6","key":"3592_CR11","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1210\/en.2007-0016","volume":"148","author":"MD DeBoer","year":"2007","unstructured":"DeBoer MD, Xin XZ, Levasseur P, Meguid MM, Suzuki S, Inui A, Marks DL (2007) Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148(6):3004\u20133012. https:\/\/doi.org\/10.1210\/en.2007-0016","journal-title":"Endocrinology"},{"issue":"4","key":"3592_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1249\/MSS.0b013e318163274d","volume":"40","author":"MM Demarzo","year":"2008","unstructured":"Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, Turatti A, Garcia SB (2008) Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis. Med Sci Sports Exerc 40(4):618\u2013621. https:\/\/doi.org\/10.1249\/MSS.0b013e318163274d","journal-title":"Med Sci Sports Exerc"},{"key":"3592_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/apm.2018.08.07","volume":"8","author":"R Dev","year":"2019","unstructured":"Dev R (2019) Measuring cachexia-diagnostic criteria. Ann. Palliat Med 8:24\u201332","journal-title":"Palliat Med"},{"issue":"8","key":"3592_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","volume":"44","author":"KCH Fearon","year":"2008","unstructured":"Fearon KCH (2008) Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer 44(8):1124\u20131132. https:\/\/doi.org\/10.1016\/j.ejca.2008.02.033","journal-title":"Eur J Cancer"},{"issue":"1","key":"3592_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/bjc.1985.153","volume":"52","author":"KC Fearon","year":"1985","unstructured":"Fearon KC, Tisdale MJ, Preston T, Plumb JA, Calman KC (1985) Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats. Br J Cancer 52(1):87\u201392","journal-title":"Br J Cancer"},{"issue":"10","key":"3592_CR16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","volume":"52","author":"KC Fearon","year":"2003","unstructured":"Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Tisdale MJ (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10):1479\u20131486","journal-title":"Gut"},{"issue":"5","key":"3592_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"issue":"2","key":"3592_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KCH Fearon","year":"2012","unstructured":"Fearon KCH, Glass DJ, Guttridge DC (2012) Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metab 16(2):153\u2013166. https:\/\/doi.org\/10.1016\/j.cmet.2012.06.011","journal-title":"Cell Metab"},{"issue":"2","key":"3592_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10(2):90\u201399. https:\/\/doi.org\/10.1038\/nrclinonc.2012.209","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3592_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S0007114511005551","volume":"108","author":"C Finocchiaro","year":"2012","unstructured":"Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, Schena M, Canuto RA (2012) Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr 108(2):327\u2013333. https:\/\/doi.org\/10.1017\/S0007114511005551","journal-title":"Br J Nutr"},{"issue":"1","key":"3592_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","volume":"21","author":"JM Garcia","year":"2013","unstructured":"Garcia JM, Friend J, Allen S (2013) Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer 21(1):129\u2013137. https:\/\/doi.org\/10.1007\/s00520-012-1500-1","journal-title":"Support Care Cancer"},{"issue":"2","key":"3592_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","volume":"4","author":"DW Gould","year":"2013","unstructured":"Gould DW, Lahart I, Carmichael AR, Koutedakis Y, Metsios GS (2013) Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia, Sarcop Muscle 4(2):111\u2013124. https:\/\/doi.org\/10.1007\/s13539-012-0096-0","journal-title":"J Cachexia, Sarcop Muscle"},{"issue":"3","key":"3592_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jcsm.12055","volume":"6","author":"AJ Grande","year":"2015","unstructured":"Grande AJ, Silva V, Maddocks M (2015) Exercise for cancer cachexia in adults: executive summary of a Cochrane Collaboration systematic review. J Cachexia, Sarcop Muscle 6(3):208\u2013211. https:\/\/doi.org\/10.1002\/jcsm.12055","journal-title":"J Cachexia, Sarcop Muscle"},{"issue":"5","key":"3592_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0148607112460682","volume":"37","author":"M Holecek","year":"2013","unstructured":"Holecek M (2013) Side effects of long-term glutamine supplementation. JPEN J Parenter Enteral Nutr 37(5):607\u2013616. https:\/\/doi.org\/10.1177\/0148607112460682","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"5297","key":"3592_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297):218\u2013220. https:\/\/doi.org\/10.1126\/science.275.5297.218","journal-title":"Science"},{"issue":"2","key":"3592_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/jco.2002.20.2.567","volume":"20","author":"A Jatoi","year":"2002","unstructured":"Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Christensen B (2002) Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 20(2):567\u2013573. https:\/\/doi.org\/10.1200\/jco.2002.20.2.567","journal-title":"J Clin Oncol"},{"key":"3592_CR27","doi-asserted-by":"publisher","first-page":"Cd012229","DOI":"10.1002\/14651858.CD012229.pub2","volume":"2","author":"MN Khatib","year":"2018","unstructured":"Khatib MN, Shankar AH, Kirubakaran R, Gaidhane A, Gaidhane S, Simkhada P, Quazi Syed Z (2018) Ghrelin for the management of cachexia associated with cancer. Cochrane Database Syst Re 2:Cd012229. https:\/\/doi.org\/10.1002\/14651858.CD012229.pub2","journal-title":"Cochrane Database Syst Re"},{"issue":"12","key":"3592_CR28","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.bcp.2010.06.036","volume":"80","author":"A Link","year":"2010","unstructured":"Link A, Balaguer F, Goel A (2010) Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80(12):1771\u20131792. https:\/\/doi.org\/10.1016\/j.bcp.2010.06.036","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"3592_CR29","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1200\/jco.1999.17.10.3299","volume":"17","author":"CL Loprinzi","year":"1999","unstructured":"Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Christensen BJ (1999) Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia. J Clin Oncol 17(10):3299\u20133306. https:\/\/doi.org\/10.1200\/jco.1999.17.10.3299","journal-title":"J Clin Oncol"},{"issue":"9","key":"3592_CR30","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/cncr.20160","volume":"100","author":"K Lundholm","year":"2004","unstructured":"Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function. Cancer 100(9):1967\u20131977. https:\/\/doi.org\/10.1002\/cncr.20160","journal-title":"Cancer"},{"issue":"8","key":"3592_CR31","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/cncr.24917","volume":"116","author":"K Lundholm","year":"2010","unstructured":"Lundholm K, Gunnebo L, Korner U, Iresjo BM, Engstrom C, Hyltander A, Bosaeus I (2010) Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer 116(8):2044\u20132052. https:\/\/doi.org\/10.1002\/cncr.24917","journal-title":"Cancer"},{"issue":"1","key":"3592_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00520-009-0722-3","volume":"18","author":"G Mantovani","year":"2010","unstructured":"Mantovani G, Madeddu C (2010) Cancer cachexia: Medical management. Support Care Cancer 18(1):1\u20139. https:\/\/doi.org\/10.1007\/s00520-009-0722-3","journal-title":"Support Care Cancer"},{"issue":"5","key":"3592_CR33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/1055-9965.epi-05-0538","volume":"15","author":"G Mantovani","year":"2006","unstructured":"Mantovani G, Maccio A, Madeddu C, Gramignano G, Lusso MR, Serpe R, Deiana L (2006) A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia\/cachexia and oxidative stress. Cancer Epidemiol Biomark Prev 15(5):1030\u20131034. https:\/\/doi.org\/10.1158\/1055-9965.epi-05-0538","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"3592_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0002-9610(02)00823-1","volume":"183","author":"PE May","year":"2002","unstructured":"May PE, Barber A, D\u2019Olimpio JT, Hourihane A, Abumrad NN (2002) Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 183(4):471\u2013479","journal-title":"Am J Surg"},{"issue":"3\u20134","key":"3592_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","volume":"79","author":"DC McMillan","year":"1999","unstructured":"McMillan DC, Wigmore SJ, Fearon KC, O\u2019Gorman P, Wright CE, McArdle CS (1999) A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79(3\u20134):495\u2013500. https:\/\/doi.org\/10.1038\/sj.bjc.6690077","journal-title":"Br J Cancer"},{"issue":"5","key":"3592_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","volume":"90","author":"AW Moses","year":"2004","unstructured":"Moses AW, Slater C, Preston T, Barber MD, Fearon KC (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90(5):996\u20131002. https:\/\/doi.org\/10.1038\/sj.bjc.6601620","journal-title":"Br J Cancer"},{"issue":"10","key":"3592_CR37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/bjc.2011.391","volume":"105","author":"RA Murphy","year":"2011","unstructured":"Murphy RA, Yeung E, Mazurak VC, Mourtzakis M (2011) Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer 105(10):1469\u20131473. https:\/\/doi.org\/10.1038\/bjc.2011.391","journal-title":"Br J Cancer"},{"issue":"2","key":"3592_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11739-010-0426-1","volume":"6","author":"M Muscaritoli","year":"2011","unstructured":"Muscaritoli M, Molfino A, Gioia G, Laviano A, Fanelli FR (2011) The \u201cparallel pathway\u201d: A novel nutritional and metabolic approach to cancer patients. Intern Emerg Med 6(2):105\u2013112. https:\/\/doi.org\/10.1007\/s11739-010-0426-1","journal-title":"Intern Emerg Med"},{"issue":"2","key":"3592_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/nu10020206","volume":"10","author":"K Nakamura","year":"2018","unstructured":"Nakamura K, Tonouchi H, Sasayama A, Ashida K (2018) A Ketogenic formula prevents tumor progression and cancer cachexia by attenuating systemic inflammation in colon 26 tumor-bearing mice. Nutrients 10(2):206. https:\/\/doi.org\/10.3390\/nu10020206","journal-title":"Nutrients"},{"issue":"6","key":"3592_CR40","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1210\/jc.2003-031768","volume":"89","author":"NM Neary","year":"2004","unstructured":"Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Bloom SR (2004) Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89(6):2832\u20132836. https:\/\/doi.org\/10.1210\/jc.2003-031768","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3592_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/082585979401000105","volume":"10","author":"K Nelson","year":"1994","unstructured":"Nelson K, Walsh D, Deeter P, Sheehan F (1994) A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J Palliat Care 10(1):14\u201318","journal-title":"J Palliat Care"},{"key":"3592_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2017.07.023","volume":"112","author":"K Nishie","year":"2017","unstructured":"Nishie K, Yamamoto S, Nagata C, Koizumi T, Hanaoka M (2017) Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis. Lung Cancer 112:25\u201334. https:\/\/doi.org\/10.1016\/j.lungcan.2017.07.023","journal-title":"Lung Cancer"},{"issue":"1\u20132","key":"3592_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1439-0396.2000.00272.x","volume":"84","author":"P Ostaszewski","year":"2000","unstructured":"Ostaszewski P, Kostiuk S, Balasi\u0144ska B, Jank M, Papet I, Glomot F (2000) The leucine metabolite 3-hydroxy-3-methylbutyrate (HMB) modifies protein turnover in muscles of laboratory rats and domestic chickens in vitro. J Anim Physiol Anim Nutr 84(1\u20132):1\u20138. https:\/\/doi.org\/10.1046\/j.1439-0396.2000.00272.x","journal-title":"J Anim Physiol Anim Nutr"},{"issue":"2","key":"3592_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/PPO.0000000000000100","volume":"21","author":"M-F Penet","year":"2015","unstructured":"Penet M-F, Bhujwalla ZM (2015) Cancer cachexia, recent advances, and future directions. Cancer J (Sudbury, Mass.) 21(2):117\u2013122. https:\/\/doi.org\/10.1097\/PPO.0000000000000100","journal-title":"Cancer J (Sudbury, Mass.)"},{"key":"3592_CR45","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"PE Porporato","year":"2016","unstructured":"Porporato PE (2016) Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5:e200. https:\/\/doi.org\/10.1038\/oncsis.2016.3","journal-title":"Oncogenesis"},{"key":"3592_CR46","unstructured":"Primers NRD (2018) Cancer-associated cachexia"},{"key":"3592_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004310.pub3","author":"V Ruiz Garcia","year":"2013","unstructured":"Ruiz Garcia V, L\u00f3pez-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Marti S (2013b) Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004310.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"3592_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004310.pub3","author":"V Ruiz Garcia","year":"2013","unstructured":"Ruiz Garcia V, L\u00f3pez-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Marti S (2013a) Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syste Rev. https:\/\/doi.org\/10.1002\/14651858.CD004310.pub3","journal-title":"Cochrane Database Syste Rev"},{"key":"3592_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","volume":"127","author":"M Sadeghi","year":"2018","unstructured":"Sadeghi M, Keshavarz-Fathi M, Baracos V, Arends J, Mahmoudi M, Rezaei N (2018) Cancer cachexia: diagnosis, assessment, and treatment. Crit Rev Oncol Hematol 127:91\u2013104. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.006","journal-title":"Crit Rev Oncol Hematol"},{"key":"3592_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2049-3002-2-18","volume":"2","author":"SK Shukla","year":"2014","unstructured":"Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, Singh PK (2014) Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab 2:18\u201318. https:\/\/doi.org\/10.1186\/2049-3002-2-18","journal-title":"Cancer Metab"},{"issue":"3","key":"3592_CR51","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","volume":"8","author":"TS Solheim","year":"2018","unstructured":"Solheim TS, Laird BJA, Balstad TR, Bye A, Stene G, Baracos V, Fearon K (2018) Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Support Palliat Care 8(3):258\u2013265. https:\/\/doi.org\/10.1136\/bmjspcare-2017-001440","journal-title":"BMJ Support Palliat Care"},{"issue":"21","key":"3592_CR52","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1200\/jco.2005.05.1847","volume":"24","author":"F Strasser","year":"2006","unstructured":"Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Cerny T (2006) Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 24(21):3394\u20133400. https:\/\/doi.org\/10.1200\/jco.2005.05.1847","journal-title":"J Clin Oncol"},{"issue":"2","key":"3592_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","volume":"98","author":"F Strasser","year":"2008","unstructured":"Strasser F, Lutz TA, Maeder MT, Thuerlimann B, Bueche D, Tsch\u00f6p M, Cerny T (2008) Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: A randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 98(2):300\u2013308. https:\/\/doi.org\/10.1038\/sj.bjc.6604148","journal-title":"Br J Cancer"},{"issue":"2","key":"3592_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00520-009-0640-4","volume":"18","author":"LA Taylor","year":"2010","unstructured":"Taylor LA, Pletschen L, Arends J, Unger C, Massing U (2010) Marine phospholipids\u2013a promising new dietary approach to tumor-associated weight loss. Support Care Cancer 18(2):159\u2013170. https:\/\/doi.org\/10.1007\/s00520-009-0640-4","journal-title":"Support Care Cancer"},{"key":"3592_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17:519\u2013531","journal-title":"Lancet Oncol"},{"issue":"3","key":"3592_CR56","first-page":"209","volume":"3","author":"MJ Tisdale","year":"2005","unstructured":"Tisdale MJ (2005) The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol 3(3):209\u2013217","journal-title":"J Support Oncol"},{"issue":"2","key":"3592_CR57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89(2):381\u2013410. https:\/\/doi.org\/10.1152\/physrev.00016.2008","journal-title":"Physiol Rev"},{"key":"3592_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/bjc.1987.149","volume":"56","author":"MJ Tisdale","year":"1987","unstructured":"Tisdale MJ, Brennan RA, Fearon KC (1987) Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 56:39. https:\/\/doi.org\/10.1038\/bjc.1987.149","journal-title":"Br J Cancer"},{"issue":"3","key":"3592_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ejcn.2011.214","volume":"66","author":"BS van der Meij","year":"2012","unstructured":"van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, Smit EF, van Leeuwen PA (2012) Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 66(3):399\u2013404. https:\/\/doi.org\/10.1038\/ejcn.2011.214","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"3592_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","volume":"1","author":"S von Haehling","year":"2010","unstructured":"von Haehling S, Anker SD (2010) Cachexia as a major underestimated and unmet medical need: Facts and numbers. J Cachexia Sarcop Muscle 1(1):1\u20135. https:\/\/doi.org\/10.1007\/s13539-010-0002-6","journal-title":"J Cachexia Sarcop Muscle"},{"issue":"7","key":"3592_CR61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/hed.21580","volume":"33","author":"HG Weed","year":"2011","unstructured":"Weed HG, Ferguson ML, Gaff RL, Hustead DS, Nelson JL, Voss AC (2011) Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid. Head Neck 33(7):1027\u20131033. https:\/\/doi.org\/10.1002\/hed.21580","journal-title":"Head Neck"},{"key":"3592_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2110-5820-1-25","volume":"1","author":"J Wernerman","year":"2011","unstructured":"Wernerman J (2011) Glutamine supplementation. Ann Intensive Care 1:25\u201325. https:\/\/doi.org\/10.1186\/2110-5820-1-25","journal-title":"Ann Intensive Care"},{"issue":"4","key":"3592_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/nano.2006.1.4.411","volume":"1","author":"S-S Yeh","year":"2006","unstructured":"Yeh S-S, Schuster MW (2006) Megestrol acetate in cachexia and anorexia. Int J Nanomed 1(4):411\u2013416","journal-title":"Int J Nanomed"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03592-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-021-03592-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03592-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T18:06:22Z","timestamp":1617645982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-021-03592-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3592"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03592-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AJK\u2014None. DSH\u2014Grants from Bayer, Lilly, Genentech, LOXO, Pfizer, Amgen, Mirati, Ignyta, Merck, Daichii-Sanko, Eisai, Adaptimmune, Abbvie, Astra-Zeneca, BMS, Genmab, Infinity, Kite, Kyowa, Medimmune, Molecular Template, Novartis, and Takeda; personal fees from Mirna and LOXO; other from Bayer, Baxter, Guidepoint Global, Oncoresponse, Janssen, and Molecular Match; all outside the submitted work. GCG\u2014None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}